Ovarian cancer symptoms can include ... magnetic resonance imaging (MRI), and positron-emission tomography (PET). These imaging studies provide a more detailed picture of the cancer and can ...

The study reveals that AI systems offer promising accuracy in predicting treatment outcomes, particularly when used to ...

Ovarian cancer is a relatively manageable malignancy when diagnosed at an early stage, but late-stage detection almost always translates into a poor prognosis. Researchers have been vigorously ...

Researchers at Karolinska Institutet have uncovered a unique ability of a special subtype of natural killer cells in the ...

INX-315 is an oral, investigational selective cyclin-dependent kinase 2 (CDK2) inhibitor. The designation was based on preclinical data as well as interim data from the ongoing phase 1/2 INX-315-01 ...

If you have ovarian cancer, your outcomes will be better if you are treated by a gynecologic oncologist right from the beginning. Fred Hutch Cancer Center has more gynecologic oncologists than any ...

The selective CDK2 inhibitor INX-315 has been given FDA fast track designation for use in CCNE1-amplified, platinum-resistant ...

RICHMOND, Va. (WRIC) — A group of scientists at Virginia Commonwealth University (VCU) may have the key to discovering cancer’s origins within the body, as well as insights into new treatment ...

Individuals who transition from overweight to obese during adulthood may face a higher ovarian cancer risk, highlighting the ...

High-grade serous ovarian cancer (HGSOC) presents challenges in prognostic prediction. This study aimed to develop a universal foundation model-driven multimodal model (FoMu model) to assess the ...